Not applicableStudy completedNCT00002375What this trial is testingSafety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected PatientsWho this might be right forHIV Infections Merck Sharp & Dohme LLC 24
Post-approval studies (Phase 4)UnknownNCT04993872What this trial is testingPharmacokinetics of Calcineurin & mTOR Inhibitors in HIV-1 Infected Kidney Transplant Recipients After Switch to BIC/FTC/TAFWho this might be right forHIV-infected Patient Kidney Transplant Recipient Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba 5
Post-approval studies (Phase 4)Study completedNCT00287677What this trial is testingInduction and Expansion of T Cell Repertoire Using Growth Hormone and Vaccination in HIV-1 Infected PatientsWho this might be right forHIV Infections Germans Trias i Pujol Hospital 33
Large-scale testing (Phase 3)Study completedNCT03913195What this trial is testingStudy of the Safety of Trogarzo™ Administered as an Undiluted "IV Push" or an Intramuscular InjectionWho this might be right forHIV-1-infection TaiMed Biologics Inc. 43
Large-scale testing (Phase 3)Study completedNCT02006745What this trial is testingOpen Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT)Who this might be right forHIV St Stephens Aids Trust 20
Large-scale testing (Phase 3)Study completedNCT00480792What this trial is testingTrial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected PatientsWho this might be right forHIV Infections ANRS, Emerging Infectious Diseases 437
Not applicableStudy completedNCT00002404What this trial is testingThe Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected PatientsWho this might be right forHerpes SimplexHIV Infections Glaxo Wellcome 30
Post-approval studies (Phase 4)Study completedNCT04388904What this trial is testingRapid Reinitiation of a Single Tablet Antiretroviral Therapy Using Symtuza® in HIV-1 Infected Treatment-Experienced Patients Off Therapy. (ReSTART)Who this might be right forHIV-1-infection The Crofoot Research Center, Inc. 75
Testing effectiveness (Phase 2)Study completedNCT01549119What this trial is testingPhase I/IIa Dose-escalation Clinical Study of VAC-3SWho this might be right forHIV-1 Infection InnaVirVax 33
Post-approval studies (Phase 4)Study completedNCT03683524What this trial is testingEFFICACY AND SAFETY OF A SIMPLIFICATION STRATEGY BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS OPTIMIZED TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS CARRYING ARCHIVED MULTIDRUG RESISTANCE MUTATIONSWho this might be right forHIV-1 Infection Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 96
Testing effectiveness (Phase 2)Study completedNCT00056641What this trial is testingDual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected PatientsWho this might be right forHIV Infections Boehringer Ingelheim 328
Large-scale testing (Phase 3)Study completedNCT00421551What this trial is testingStudy Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136Who this might be right forHIV Infections French National Agency for Research on AIDS and Viral Hepatitis 225
Post-approval studies (Phase 4)UnknownNCT00011895What this trial is testingSafety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsWho this might be right forHIV Infections GlaxoSmithKline 400
Not applicableEnrolling By InvitationNCT02699736What this trial is testingEuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIVWho this might be right forHIVHepatitis BHepatitis C+10 more Rigshospitalet, Denmark 23,000
Large-scale testing (Phase 3)UnknownNCT04022967What this trial is testingANRS 12372 MODERATO StudyWho this might be right forHIV-1-infection ANRS, Emerging Infectious Diseases 480
Testing effectiveness (Phase 2)Study completedNCT00080106What this trial is testingEffectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected PatientsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 114
Testing effectiveness (Phase 2)Study completedNCT00976404What this trial is testingTherapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral ReservoirWho this might be right forHIV Infection Robert L. Murphy 28
Large-scale testing (Phase 3)Ended earlyNCT03333083What this trial is testingStudy With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current RegimenWho this might be right forHIV SeropositivityHIV InfectionsHIV-1-infection Judit Pich 17
Not applicableStudy completedNCT00006441What this trial is testingEffectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIVWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 398
Large-scale testing (Phase 3)WithdrawnNCT00011128What this trial is testingSalvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV TreatmentWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID)